• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于截短型人胃泌素释放肽序列的新型 111In-放射性配体用于肿瘤诊断:合成与临床前比较。

Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison.

机构信息

Molecular Radiopharmacy, INRASTES, National Center for Scientific Research "Demokritos" , GR-153 10 Athens, Greece.

出版信息

J Med Chem. 2013 Nov 14;56(21):8579-87. doi: 10.1021/jm4010237. Epub 2013 Oct 23.

DOI:10.1021/jm4010237
PMID:24094035
Abstract

Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different and yet unexplored approach, we have developed four novel (111)In-labeled truncated analogs of the human 27-mer GRP after conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) at the N-terminus of GRP(13/14/17/18-27) fragments. Analog affinities for the human GRPR determined against [(125)I-Tyr(4)]BBN were at the nanomolar level and dependent on truncation site. The respective (111)In radioligands specifically internalized in GRPR-expressing PC-3 cells. The shorter chain [(111)In-DOTA]GRP(17/18-27) analogs showed higher metabolic stability in mice. Radioligands specifically localized in human PC-3 xenografts in SCID mice, with [(111)In-DOTA]GRP(17-27) exhibiting the most favorable pharmacokinetic profile. This study has demonstrated the efficacy of human GRP-based radiopeptides to target GRPR-positive lesions in vivo and has revealed the impact of GRP chain length on key biological parameters of resulting radiotracers.

摘要

蛙十四肽缩胆囊素(BBN)的放射性标记类似物已被提议用于胃泌素释放肽受体(GRPR)表达肿瘤的诊断和治疗。采用一种不同且尚未探索的方法,我们在 GRP(13/14/17/18-27)片段的 N 末端缀合了 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)后,开发了四个新型的(111)In 标记的人 27 肽 GRP 截断类似物。针对 [(125)I-Tyr(4)]BBN 测定的人 GRPR 亲和力为纳摩尔级,并且依赖于截断位点。相应的(111)In 放射性配体特异性地在表达 GRPR 的 PC-3 细胞中内化。较短链 [(111)In-DOTA]GRP(17/18-27)类似物在小鼠中表现出更高的代谢稳定性。放射性配体特异性地定位于 SCID 小鼠中的人 PC-3 异种移植物中,其中 [(111)In-DOTA]GRP(17-27)表现出最有利的药代动力学特征。这项研究证明了基于人 GRP 的放射性肽能够在体内靶向 GRPR 阳性病变,并揭示了 GRP 链长对所得放射性示踪剂关键生物学参数的影响。

相似文献

1
Tumor diagnosis with new 111In-radioligands based on truncated human gastrin releasing peptide sequences: synthesis and preclinical comparison.基于截短型人胃泌素释放肽序列的新型 111In-放射性配体用于肿瘤诊断:合成与临床前比较。
J Med Chem. 2013 Nov 14;56(21):8579-87. doi: 10.1021/jm4010237. Epub 2013 Oct 23.
2
99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.基于人源 GRP(18-27)的 99mTc 放射性示踪剂:合成与比较评价。
J Nucl Med. 2013 Oct;54(10):1797-803. doi: 10.2967/jnumed.112.118695. Epub 2013 Sep 5.
3
Gastrin releasing peptide receptor-directed radioligands based on a bombesin antagonist: synthesis, (111)in-labeling, and preclinical profile.基于蛙皮素拮抗剂的胃泌素释放肽受体导向放射性配体:合成、(111)In 标记和临床前特征。
J Med Chem. 2013 Mar 28;56(6):2374-84. doi: 10.1021/jm301692p. Epub 2013 Mar 8.
4
Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.酰胺-三唑转换与体内抑制中性内肽酶方法以促进放射性肽靶向胃泌素释放肽受体阳性肿瘤
Nucl Med Biol. 2017 Sep;52:57-62. doi: 10.1016/j.nucmedbio.2017.06.001. Epub 2017 Jun 10.
5
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.新型111铟标记的蛙皮素类似物系列,作为潜在的放射性药物用于特异性靶向人前列腺癌细胞上表达的胃泌素释放肽受体。
J Nucl Med. 2003 May;44(5):823-31.
6
Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.新型蛙皮素类似物用于胃泌素释放肽受体成像的临床前评估。
Cancer Biother Radiopharm. 2011 Jun;26(3):309-16. doi: 10.1089/cbr.2010.0912. Epub 2011 Jun 28.
7
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.用64Cu-DOTA-[Lys3]蛙皮素对人前列腺癌异种移植瘤中GRP受体表达进行微PET和放射自显影成像。
J Nucl Med. 2004 Aug;45(8):1390-7.
8
Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.(177)Lu标记的糖化蛙皮素类似物用于胃泌素释放肽受体阳性前列腺肿瘤靶向的临床前药代动力学、生物分布、成像及治疗效果
Nucl Med Biol. 2015 Mar;42(3):234-41. doi: 10.1016/j.nucmedbio.2014.10.008. Epub 2014 Oct 22.
9
Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.用90Y和177Lu标记的DOTA衍生铃蟾肽类似物的比较研究:体内外评价
Nucl Med Biol. 2009 Aug;36(6):591-603. doi: 10.1016/j.nucmedbio.2009.03.006.
10
Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.在人前列腺腺癌小鼠模型中对两种64Cu标记的蛙皮素类似物进行体外和体内比较评估。
Nucl Med Biol. 2006 Apr;33(3):371-80. doi: 10.1016/j.nucmedbio.2005.12.011. Epub 2006 Mar 9.

引用本文的文献

1
Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists.癌症诊疗中的肽放射性配体:激动剂与拮抗剂
Pharmaceuticals (Basel). 2023 Apr 30;16(5):674. doi: 10.3390/ph16050674.
2
Localization of Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses.锝标记的胃泌素释放肽类似物在表达胃泌素释放肽受体的肿瘤中的定位:肽长度和中性内肽酶抑制对生物学反应的影响
Pharmaceuticals (Basel). 2019 Mar 20;12(1):42. doi: 10.3390/ph12010042.
3
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.
体内稳定的 SB3,一种有吸引力的 GRPR 拮抗剂,用于前列腺癌的术前和术中成像。
Mol Imaging Biol. 2018 Dec;20(6):973-983. doi: 10.1007/s11307-018-1185-z.
4
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.胃泌素释放肽受体拮抗剂[⁶⁸Ga]SB3与PET/CT的临床前及首次临床经验
Eur J Nucl Med Mol Imaging. 2016 May;43(5):964-973. doi: 10.1007/s00259-015-3232-1. Epub 2015 Dec 2.